5-aminosalicylates and colorectal cancer: preventive role in chronic inflammatory bowel disease?

被引：4
|
作者：
Desreumaux, P [1 ]
Romano, O [1 ]
机构：
[1] Univ Lille, Equipe INSERM, Serv Maladies Appareil Digestif, F-0114 Lille, France
来源：
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE | 2004年 / 28卷 / 05期
关键词：
D O I：
10.1016/S0399-8320(04)94978-0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：509 / 509
页数：1
相关论文
共 50 条
  • [31] Tolerability of aminosalicylates in inflammatory bowel disease
    Ishaq, S
    Green, JRB
    BIODRUGS, 2001, 15 (05) : 339 - 349
  • [32] Aminosalicylates in the treatment of inflammatory bowel disease
    Sutherland, LR
    INFLAMMATORY BOWEL DISEASES, 1998, 4 (02) : 113 - 113
  • [33] Tolerability of Aminosalicylates in Inflammatory Bowel Disease
    Sauid Ishaq
    Jonathan R.B. Green
    BioDrugs, 2001, 15 : 339 - 349
  • [34] The Role of Cyclophilins in Inflammatory Bowel Disease and Colorectal Cancer
    Liang, Lifang
    Lin, Rongxiao
    Xie, Ying
    Lin, Huaqing
    Shao, Fangyuan
    Rui, Wen
    Chen, Hongyuan
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2021, 17 (10): : 2548 - 2560
  • [35] 5-AMINOSALICYLATES USED IN INFLAMMATORY BOWEL-DISEASE (IBD) INHIBIT LPS INDUCED ENDOTHELIAL-CELL PROCOAGULANT ACTIVITY (EPCA)
    HUDSON, M
    NYGARD, G
    MAZURE, G
    DHILLON, AP
    POUNDER, RE
    WAKEFIELD, AJ
    GASTROENTEROLOGY, 1993, 104 (04) : A716 - A716
  • [36] Efficacy of 5-Aminosalicylates for the Maintenance of Remission in Crohn's Disease
    Akobeng, Anthony K.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 (10): : 1857 - 1857
  • [37] Continuing or stopping 5-aminosalicylates in patients with inflammatory bowel disease on anti-TNF therapy: A nationwide population-based study
    Seo, Jeongkuk
    Kim, Seonok
    Hong, Seung Wook
    Hwang, Sung Wook
    Park, Sang Hyoung
    Yang, Dong-Hoon
    Byeon, Jeong-Sik
    Myung, Seung-Jae
    Yang, Suk-Kyun
    Kim, Ye-Jee
    Ye, Byong Duk
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 60 (03) : 389 - 400
  • [38] Effect of 5-aminosalicylates (5-ASAS) on renal function in patients with inflammatory bowel disease (IBD): 4-year follow-up study
    Gisbert, Javier P.
    Luna, M.
    Gonzalez-lama, Y.
    Mate, J.
    GASTROENTEROLOGY, 2007, 132 (04) : A176 - A176
  • [39] Letter: rationalising aminosalicylates in inflammatory bowel disease
    Nicolaides, Steven
    Vasudevan, Abhinav
    van Langenberg, Daniel
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (10) : 1619 - 1620
  • [40] AMINOSALICYLATES FOR THE TREATMENT OF INFLAMMATORY BOWEL-DISEASE
    LEICHTNER, AM
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 1995, 21 (03): : 245 - 252
12345